Bio-entrepreneurs' bugbear: Regulatory rigmarole.
Perspect Clin Res
; 15(3): 122-127, 2024.
Article
em En
| MEDLINE
| ID: mdl-39140019
ABSTRACT
Indian biotech startup sector - a rapidly growing business segment focused on the development of innovative products has the potential to make significant contributions to the country's economy. Indian bio-entrepreneurs' optimistic expectation of rapidly moving product development from bench to bedside faces tremendous challenges of the complex Indian regulatory system, which is shaped by a diversity of regulatory authorities, rules, guidelines, and processes. This brief review discusses specific regulatory issues faced by bio-entrepreneurs investing in a variety of innovative products - new drugs, vaccines, medical devices, cell, and gene therapy and suggests approaches which can ease Indian entrepreneur's endeavors.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Perspect Clin Res
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Índia
País de publicação:
Índia